Recently, researchers have developed a machine learning approach that can predict the fitness trajectories of cancer cells in response to […]
At the Festival of Genomics and Biodata, Paul Nioi (Senior Director, Research, Alnylam Pharmaceuticals) joined us to explore how population […]
With drug discovery being an expensive process and genetic-based drugs being more likely to succeed, the level of investment in […]
The UKB-ESC research team has published a paper that explains how the collaboration between the UK Biobank and biopharmaceutical companies […]
Clinical trials are used to determine the efficacy of a drug in patients. However, effective clinical trials that have a large […]
The National Institutes of Health (NIH) have funded a five-year effort to use state-of-the-art artificial intelligence methods to study Alzheimer’s […]
In a recent perspective, published in Nature Genetics, Amalio Telenti and Xiaoqian Jiang argue that aspects of data generation, infrastructure […]
Differences in genetics, physiology, race, ethnicity, age, and sex, as well as numerous other extrinsic factors, are known to affect […]
Introduction: Single-cell sequencing technology has been advanced by the falling sequencing costs, a boom in microfluidics and combinatorial indexing strategies. […]
Dr Rona Strawbridge has been using genetics to try to understand complex diseases, who’s work has focused much on obesity, type 2 diabetes and cardiovascular disease, and more recently serious mental illness. We managed to have a chat with Rona ahead of her speaking at the Festival of Genomics about her work and why she’s excited to be speaking at the festival this year.
